[Agrammatism and its symptoms]. / El agramatismo y su sintomatología.

INTRODUCTION: We present a review the issue of agrammatism in order to examine its symptoms, the regularity with which they are observed, and the proposals suggested within the framework of Cognitive Neuropsychology to account for them. DEVELOPMENT: First, we focus on the debate regarding the status of agrammatism as an aphasic category with both theoretical and clinical validity, presenting two confronted views. On the one hand, the view that argues against the category of agrammatism due the variable performance of agrammatic patients in linguistic tasks. On the other hand, we present the view of those authors who defend, despite the variability, the notion of agrammatism as an aphasic syndrome. In the second section of the paper, we discussed the different symptoms that, on the basis of the available evidence, have been associated to agrammatism and the proposed explanations. We start by discussing the symptoms that agrammatic patients present in language production; in particular, we highlight the following: a) problems related to grammatical morphemes; b) a reduced sentence length; c) a noun-verb dissociation, with a better performance with nouns; d) difficulties in sentence construction, and finally, e) alteration in word order. Then, we discuss the symptoms that agrammatic patients have shown in language comprehension. CONCLUSION: In general, on the basis of the different agrammatic symptoms we have discussed, we favour the view of agrammatism as multicomponential syndrome rather than unitary one, with deficits in both morpholexical and syntactic language components.

Psychopharmacological treatment in borderline personality disorder.

Borderline personality disorder is a disorder with important social and clinical repercussions, which has been treated mainly by psychotherapy. In recent years, the syndromic analysis of this disorder has allowed us to identify different symptoms capable of being improved with psychopharmacology treatment. Thus, its complex symptomatology could be included in four clinical dimensions: impulsive-aggressive, affective instability, cognitive- perceptive and anxiety-inhibition. Antidepressants, mood stabilizers, antipsychotics, anxiolytics, or more recently omega-3 fatty acids have shown efficacy in the treatment of symptomatic dimensions of this disease. We have reviewed scientific articles (reviews, clinical trials or clinical guidelines) published over the last ten years and have proposed therapeutic algorithms for psychopharmacology management in these patients.

Identifying the null subject: evidence from event-related brain potentials.

Event-related brain potentials (ERPs) were recorded during spoken language comprehension to study the on-line effects of gender agreement violations in controlled infinitival complements. Spanish sentences were constructed in which the complement clause contained a predicate adjective marked for syntactic gender. By manipulating the gender of the antecedent (i.e., the controller) of the implicit subject while holding constant the gender of the adjective, pairs of grammatical and ungrammatical sentences were created. The detection of such a gender agreement violation would indicate that the parser had established the coreference relation between the null subject and its antecedent. The results showed a complex biphasic ERP (i.e., an early negativity with prominence at anterior and central sites, followed by a centroparietal positivity) in the violating condition as compared to the non-violating conditions. The brain reacts to NP-adjective gender agreement violations within a few hundred milliseconds of their occurrence. The data imply that the parser has properly coindexed the null subject of an infinitive clause with its antecedent.